Sopida Pimcharoen

All Publications

• Acid-degradable lipid nanoparticles enhance the delivery of mRNA. Nature nanotechnology Zhao, S., Gao, K., Han, H., Stenzel, M., Yin, B., Song, H., Lawanprasert, A., Nielsen, J. E., Sharma, R., Arogundade, O. H., Pimcharoen, S., Chen, Y. J., Paul, A., Tuma, J., Collins, M. G., Wyle, Y., Cranick, M. G., Burgstone, B. W., Perez, B. S., Barron, A. E., Smith, A. M., Lee, H. Y., Wang, A., Murthy, N. 2024

  Abstract

  Lipid nanoparticle (LNP)-mRNA complexes are transforming medicine. However, the medical applications of LNPs are limited by their low endosomal disruption rates, high toxicity and long tissue persistence times. LNPs that rapidly hydrolyse in endosomes (RD-LNPs) could solve the problems limiting LNP-based therapeutics and dramatically expand their applications but have been challenging to synthesize. Here we present an acid-degradable linker termed 'azido-acetal' that hydrolyses in endosomes within minutes and enables the production of RD-LNPs. Acid-degradable lipids composed of polyethylene glycol lipids, anionic lipids and cationic lipids were synthesized with the azido-acetal linker and used to generate RD-LNPs, which significantly improved the performance of LNP-mRNA complexes in vitro and in vivo. Collectively, RD-LNPs delivered mRNA more efficiently to the liver, lung, spleen and brains of mice and to haematopoietic stem and progenitor cells in vitro than conventional LNPs. These experiments demonstrate that engineering LNP hydrolysis rates in vivo has great potential for expanding the medical applications of LNPs.

  View details for DOI 10.1038/s41565-024-01765-4

  View details for PubMedID 39179796

  View details for PubMedCentralID 10190134